Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use

Journal of Oral Pathology and Medicine

Volumn 39, Issue 8, 2010, Pages 599-604

  Jalouli, Jamshid ^a   Ibrahim, Salah O ^b   Sapkota, Dipak ^b   Jalouli, Miranda M ^a   Vasstrand, Endre N ^b   Hirsch, Jan M ^a   Larsson, Per Anders ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Epstein Barr virus; herpes simplex virus; human papillomavirus; oral cancer; toombak

Indexed keywords

ADULT; ARTICLE; CANCER RISK; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH MUCOSA; ORAL BIOPSY; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CYTODIAGNOSIS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RISK FACTORS; SIMPLEXVIRUS; STOMATITIS, HERPETIC; SUDAN; TOBACCO, SMOKELESS;

EID: 77956287167     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00910.x     Document Type: Article

References (33)

1. Franceschi S, Bidoli E, Herrero R, et al. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000 36 : 106 115.
2. La Vecchia C, Lucchini F, Negri E, et al. Trends of cancer mortality in Europe, 1955-1989: I, digestive sites. Eur J Cancer 1992 28 : 132 235.
3. Sankaranarayanan R, Masuyer E, Swaminathan R, et al. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998 18 : 4779 4786.
4. Zur Hausen H. Infections causing human cancer. Wiley-VCH, John Wiley, Weinheim Chichester, 2006 xiv, 517.
5. Payne P, Waterhouse JAH. Cancer incidence in five continents: a technical report, vol. 1. International Union against Cancer. Springer: Genève New York, 1966 3 8.
6. Johnson NW, Ranasinghe AW, Warnakulasuriya KA. Potentially malignant lesions and conditions of the mouth and oropharynx: natural history - cellular and molecular markers of risk. Eur J Cancer Prev 1993 2 (Suppl. 2 31 51.
7. Idris AM, Ibrahim YE, Warnakulasuriya KA, et al. Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state. Prev Med 1998 27 : 597 603.
8. Idris AM, Warnakulasuriya KA, Ibrahim YE, et al. Characterization of an amorphous deposit in the lamina propria in oral snuff users in the Sudan as collagen. J Oral Pathol Med 1998 27 : 157 162.
9. Idris AM, Nair J, Friesen M, et al. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis 1992 13 : 1001 1005.
10. Idris AM, Ahmed HM, Malik MO. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 1995 63 : 477 480.
11. Idris AM, Ibrahim SO, Vasstrand EN, et al. The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 1998 34 : 558 566.
12. Koffa M, Koumantakis E, Ergazaki M, et al. Association of herpesvirus infection with the development of genital cancer. Int J Cancer 1995 63 : 58 62.
13. Talamini R, Vaccarella S, Barbone F, et al. Oral hygiene, dentition, sexual habits and risk of oral cancer. Br J Cancer 2000 83 : 1238 1242.
14. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006 119 : 2620 2623.
15. Idris AM, Nair J, Ohshima H, et al. Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 1991 12 : 1115 1118.
16. Ibrahim SO, Bertelsen B, Kalvenes MB, et al. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS 1998 106 : 959 969.
17. Bouda M, Gorgoulis VG, Kastrinakis NG, et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000 13 : 644 653.
18. Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003 10 : 711 714.
19. Sand L, Jalouli J, Larsson PA, et al. Human papilloma viruses in oral lesions. Anticancer Res 2000 20 : 1183 1188.
20. Larsson PA, Johansson SL, Vahlne A, et al. Snuff tumorigenesis: effects of long-term snuff administration after initiation with 4-nitroquinoline-N-oxide and herpes simplex virus type 1. J Oral Pathol Med 1989 18 : 187 192.
21. Larsson PA, Edstrom S, Westin T, et al. Reactivity against herpes simplex virus in patients with head and neck cancer. Int J Cancer 1991 49 : 14 8.
22. Flaitz CM, Hicks MJ. Molecular piracy: the viral link to carcinogenesis. Oral Oncol 1998 34 : 448 453.
23. Smith HG, Horowitz N, Silverman NA, et al. Humoral immunity to herpes simplex viral-induced antigens in smokers. Cancer 1976 38 : 1155 1162.
24. Szkaradkiewicz A, Kruk-Zagajewska A, Wal M, et al. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin Exp Med 2002 2 : 137 141.
25. Campisi G, Giovannelli L, Calvino F, et al. HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. Oral Oncol 2006 42 : 638 645.
26. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000 92 : 709 720.
27. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007 29 : 779 792.
28. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009 125 : 362 366.
29. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003 95 : 1772 1783.
30. Inglis S, Shaw A, Koenig S. Chapter 11: HPV vaccines: commercial research and development. Vaccine 2006 24 (Suppl. 3 S3/99 105.
31. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005 366 : 991 998.
32. Tung YC, Lin KH, Chu PY, et al. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci 1999 15 : 256 262.
33. Elgui DE, Oliveira D. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007 247 : 182 196.